The growth factor HPPCn increases HIF-2α levels, which promote cell growth and metastasis; thus, the combination of lentivirus-mediated HIF-2α shRNA and sorafenib presented synergistically effects to prevent tumor growth49. Here, EPAS1 is linked to neoplasm.